Skip to main content

Table 4 Univariate analysis for PFS after EGFR-TKI treatment

From: Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation

Variable

95% CI

p value

Age: ≤ 65 vs. >  65 years

0.10–1.74

0.23

Sex: male vs. female

0.45–30.31

0.21

History of smoking: yes vs. no

0.12–1.99

0.32

Mutation: single vs. compound

0.13–3.82

0.70

Line of TKI treatment: first vs. later line

0.33–4.70

0.74